| TCRX Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the TCRX market cap history going back to 8/16/2021:
Also see: TCRX Shares Outstanding History and TCRX YTD Return |
As of 8/7/2026 TScan Therapeutics has a market cap of 50.55 million. Investors often follow the TCRX market cap history to compare the size of the company over time.
This page shows TCRX market capitalization trends over time, with 22 market cap datapoints presented, dating back to 8/16/2021.

| TCRX Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the TCRX market cap history going back to 8/16/2021:
Also see: TCRX Shares Outstanding History and TCRX YTD Return |
| TCRX Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||
TCRX Historical Market Cap: -25.01% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||
| TCRX Stock Price Chart |
| About TScan Therapeutics Inc |
| TScan Therapeutics, Inc. is a clinical-stage biopharmaceutical company. Co. is focused on developing a pipeline of T cell receptor-engineered T cell (TCR-T), therapies for the treatment of patients with cancer. Co.'s lead TCR-T therapy candidates, TSC-100 and TSC-101, are in clinical development for the treatment of patients with hematologic malignancies to eliminate residual disease and prevent relapse after allogeneic hematopoietic cell transplantation. Co. is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors. We show 22 historical shares outstanding datapoints in our TCRX shares outstanding history coverage, used to compute TCRX market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing TCRX market cap history over the course of time is important for investors interested in comparing TCRX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of TCRX versus a peer is one thing; comparing TCRX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like TCRX can fluctuate over the course of history. With this page we aim to empower investors researching TCRX by allowing them to research the TCRX market cap history. |
| TCRX Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: The Importance of Market Cap | |
|
| TCRX Share Performance |
| Market Cap Peers |
| TScan Therapeutics (TCRX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
TDOC Market Cap History TECH Market Cap History TECX Market Cap History TELA Market Cap History TELO Market Cap History TENX Market Cap History TERN Market Cap History TEVA Market Cap History TFFP Market Cap History TFX Market Cap History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.